Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 3895: Clonal expansion in normal endometrium and its association with endometriosis-associated ovarian cancer

Koichi Watanabe, Nobuyuki Kakiuchi, Kosuke Ieiri, Maeda Hirona, Tomonori Hirano, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Masaki Mandai, Seishi Ogawa

Cancer Res (2025) 85 (8_Supplement_1): 3895.

https://doi.org/10.1158/1538-7445.AM2025-3895

Published: 21 April 2025

View articletitled, Abstract 3895: Clonal expansion in normal endometrium and its association with endometriosis-associated ovarian cancer

Journal Articles

Abstract 2903: Evaluation of SMP-3124, a novel liposome-encapsulated CHK1 inhibitor, in patient-derived preclinical models of treatment-resistant ovarian cancer

Yuka Kumagai, Junzo Hamanishi, Ryusuke Murakami, Kana Shimizu, Yosuke Ota, Yusuke Sawayama, Naoaki Shimada, Kento Hayashi, Yoshiko Fukuoka, Steven L. Warner, Jason M. Foulks, Masaki Mandai, Makoto Matsuoka, Seiji Kamioka, Hitoshi Ban, Hiroki Umehara

Cancer Res (2025) 85 (8_Supplement_1): 2903.

https://doi.org/10.1158/1538-7445.AM2025-2903

Published: 21 April 2025

View articletitled, Abstract 2903: Evaluation of SMP-3124, a novel liposome-encapsulated CHK1 inhibitor, in patient-derived preclinical models of treatment-resistant ovarian cancer

Journal Articles

Abstract 1614: Macroscopic clonal expansion with driver mutations in normal human endometrium

Koichi Watanabe, Nobuyuki Kakiuchi, Kosuke Ieiri, Hirona Maeda, Tomonori Hirano, Sachiko Kitamura, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Hiroko Tanaka, Satoru Miyano, Masaki Mandai, Seishi Ogawa

Cancer Res (2024) 84 (6_Supplement): 1614.

https://doi.org/10.1158/1538-7445.AM2024-1614

Published: 22 March 2024

View articletitled, Abstract 1614: Macroscopic clonal expansion with driver mutations in normal human endometrium

Journal Articles

Abstract B107: Elucidating the influence of long-chain fatty acids on ovarian cancer progression

Jumpei Ogura, Koji Yamanoi, Mana Taki, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Masaki Mandai

Cancer Res (2024) 84 (5_Supplement_2): B107.

https://doi.org/10.1158/1538-7445.OVARIAN23-B107

Published: 04 March 2024

View articletitled, Abstract B107: Elucidating the influence of long-chain fatty acids on ovarian cancer progression

Journal Articles

Abstract 128: Clonal expansion with driver mutations in normal human endometrium

Koichi Watanabe, Nobuyuki Kakiuchi, Shiro Takamatsu, Sachiko Kitamura, Mana Taki, Koji Yamanoi, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Hiroko Tanaka, Satoru Miyano, Masaki Mandai, Seishi Ogawa

Cancer Res (2023) 83 (7_Supplement): 128.

https://doi.org/10.1158/1538-7445.AM2023-128

Published: 04 April 2023

View articletitled, Abstract 128: Clonal expansion with driver mutations in normal human endometrium

Journal Articles

Abstract 5261: Development of a computational algorithm to detect fatigue of gynecologic cancer patients using lifelogs

Ken Yamaguchi, Nozomi higashiyama, Akihiko Ueda, Shiro Takamatsu, Masayo Ukita, Mana Taki, Koji Yamanoi, Junzo Hamanishi, Masaki Mandai

Cancer Res (2022) 82 (12_Supplement): 5261.

https://doi.org/10.1158/1538-7445.AM2022-5261

Published: 15 June 2022

View articletitled, Abstract 5261: Development of a computational algorithm to detect fatigue of gynecologic cancer patients using lifelogs

Journal Articles

Abstract 6109: Clonal relationship of B cells between tertiary lymphoid structures (TLSs) and tumor infiltrating lymphocytes (TILs) in advanced endometrial cancer

Haruka Suzuki, Junzo Hamanishi, Meng Qin, Masayo Ukita, Akihiko Ueda, Shunsuke Kawahara, Koji Yamanoi, Taito Miyamoto, Shiro Takamatsu, Mana Taki, Yoko Hosoe, Takashi Kobayashi, Ken Yamaguchi, Masaki Mandai

Cancer Res (2022) 82 (12_Supplement): 6109.

https://doi.org/10.1158/1538-7445.AM2022-6109

Published: 15 June 2022

View articletitled, Abstract 6109: Clonal relationship of B cells between tertiary lymphoid structures (TLSs) and tumor infiltrating lymphocytes (TILs) in advanced endometrial cancer

Journal Articles

Abstract 2005: ZDHHC7 contributes to ferroptosis resistance through YAP localization in ovarian clear cell carcinoma

Yoko Furutake, Ken Yamaguchi, Masayo Ukita, Mana Taki, Koji Yamanoi, Junzo Hamanishi, Takashi Kobayashi, Masaki Mandai

Cancer Res (2021) 81 (13_Supplement): 2005.

https://doi.org/10.1158/1538-7445.AM2021-2005

Published: 01 July 2021

View articletitled, Abstract 2005: ZDHHC7 contributes to ferroptosis resistance through YAP localization in ovarian clear cell carcinoma

Journal Articles

Abstract 366: Identification of a clinically significant pan-cancer biomarker for homologous recombination deficiency

Shiro Takamatsu, JB Brown, Koji Yamanoi, Ken Yamaguchi, Junzo Hamanishi, Takashi Kobayashi, Masaki Mandai, Noriomi Matsumura

Cancer Res (2021) 81 (13_Supplement): 366.

https://doi.org/10.1158/1538-7445.AM2021-366

Published: 01 July 2021

View articletitled, Abstract 366: Identification of a clinically significant pan-cancer biomarker for homologous recombination deficiency

Journal Articles

Abstract 2746: CD276 in tumor cells contributes to the M2 macrophage-rich immunosuppressive tumor microenvironment via upregulating the CCL2-CCR2 axis in ovarian cancer

Taito Miyamoto, Ryusuke Murakami, Masayo Ukita, Mana Taki, Koji Yamanoi, Kaoru Abiko, Ken Yamaguchi, Junzo Hamanishi, Takashi Kobayashi, Masaki Mandai

Cancer Res (2021) 81 (13_Supplement): 2746.

https://doi.org/10.1158/1538-7445.AM2021-2746

Published: 01 July 2021

View articletitled, Abstract 2746: CD276 in tumor cells contributes to the M2 macrophage-rich immunosuppressive tumor microenvironment via upregulating the CCL2-CCR2 axis in ovarian cancer

Journal Articles

Abstract 1021: Clinical significance of tertiary lymphoid structures (TLS) and tumor-infiltrating plasma cells in ovarian cancer

Masayo Ukita, Junzo Hamanishi, Tsukasa Baba, Ryusuke Murakami, Kaoru Abiko, Masaki Mandai

Cancer Res (2018) 78 (13_Supplement): 1021.

https://doi.org/10.1158/1538-7445.AM2018-1021

Published: 01 July 2018

View articletitled, Abstract 1021: Clinical significance of tertiary lymphoid structures (TLS) and tumor-infiltrating plasma cells in ovarian cancer

Journal Articles

Abstract 3631: Passenger fusion genes are novel predictive biomarker of anti-PD-1 antibody nivolumab for ovarian cancer

Junzo Hamanishi, Ryusuke Murakami, John B. Brown, Tsukasa Baba, Kaoru Abiko, Eiji Suzuki, Masaki Mandai

Cancer Res (2018) 78 (13_Supplement): 3631.

https://doi.org/10.1158/1538-7445.AM2018-3631

Published: 01 July 2018

View articletitled, Abstract 3631: Passenger fusion genes are novel predictive biomarker of anti-PD-1 antibody nivolumab for ovarian cancer

Journal Articles

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Jin Peng, Junzo Hamanishi, Noriomi Matsumura, Kaoru Abiko, Kumuruz Murat, Tsukasa Baba, Ken Yamaguchi, Naoki Horikawa, Yuko Hosoe, Susan K. Murphy, Ikuo Konishi, Masaki Mandai

Cancer Res (2015) 75 (23): 5034–5045.

https://doi.org/10.1158/0008-5472.CAN-14-3098

Published: 30 November 2015

View articletitled, Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Includes: Supplementary data

Journal Articles

STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer

Budiman Kharma, Tsukasa Baba, Noriomi Matsumura, Hyun Sook Kang, Junzo Hamanishi, Ryusuke Murakami, Melissa M. McConechy, Samuel Leung, Ken Yamaguchi, Yuko Hosoe, Yumiko Yoshioka, Susan K. Murphy, Masaki Mandai, David G. Hunstman, Ikuo Konishi

Cancer Res (2014) 74 (22): 6519–6530.

https://doi.org/10.1158/0008-5472.CAN-14-0847

Published: 13 November 2014

View articletitled, STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer

Includes: Supplementary data

Journal Articles

Abstract LB-123: Novel function of STAT1 pathway as a modulator of tumor progression in serous papillary endometrial cancer

Budiman Kharma, Tsukasa Baba, Noriomi Matsumura, Hyun Sook Kang, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Masaki Mandai, Susan K Murphy, Ikuo Konishi

Cancer Res (2014) 74 (19_Supplement): LB-123.

https://doi.org/10.1158/1538-7445.AM2014-LB-123

Published: 01 October 2014

View articletitled, Abstract LB-123: Novel function of STAT1 pathway as a modulator of tumor progression in serous papillary endometrial cancer

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3895: Clonal expansion in normal endometrium and its association with endometriosis-associated ovarian cancer

Abstract 2903: Evaluation of SMP-3124, a novel liposome-encapsulated CHK1 inhibitor, in patient-derived preclinical models of treatment-resistant ovarian cancer

Abstract 1614: Macroscopic clonal expansion with driver mutations in normal human endometrium

Abstract B107: Elucidating the influence of long-chain fatty acids on ovarian cancer progression

Abstract 128: Clonal expansion with driver mutations in normal human endometrium

Abstract 5261: Development of a computational algorithm to detect fatigue of gynecologic cancer patients using lifelogs

Abstract 6109: Clonal relationship of B cells between tertiary lymphoid structures (TLSs) and tumor infiltrating lymphocytes (TILs) in advanced endometrial cancer

Abstract 2005: ZDHHC7 contributes to ferroptosis resistance through YAP localization in ovarian clear cell carcinoma

Abstract 366: Identification of a clinically significant pan-cancer biomarker for homologous recombination deficiency

Abstract 2746: CD276 in tumor cells contributes to the M2 macrophage-rich immunosuppressive tumor microenvironment via upregulating the CCL2-CCR2 axis in ovarian cancer

Abstract 1021: Clinical significance of tertiary lymphoid structures (TLS) and tumor-infiltrating plasma cells in ovarian cancer

Abstract 3631: Passenger fusion genes are novel predictive biomarker of anti-PD-1 antibody nivolumab for ovarian cancer

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

STAT1 Drives Tumor Progression in Serous Papillary Endometrial Cancer

Abstract LB-123: Novel function of STAT1 pathway as a modulator of tumor progression in serous papillary endometrial cancer

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only